{
  "id": 2137440,
  "title": "Stifel reiterates Nlight stock rating on limited China exposure",
  "url": "https://urgent.news/2026/08/20/stifel-reiterates-nlight-stock-rating-on-limited-china-exposure",
  "topic": "finance",
  "section": "Finance & Markets",
  "published": "2026-08-20T13:02:58.000Z",
  "source": {
    "name": "Investing.com",
    "slug": "investing-com",
    "url": "https://www.investing.com/news/analyst-ratings/stifel-reiterates-nlight-stock-rating-on-limited-china-exposure-93CH-4869842"
  },
  "original_language": "en",
  "account": "Stifel has reaffirmed its Buy rating and $85.00 price target for Nlight (LASR) stock, taking into account the company’s limited exposure to the Chinese market. Analyst Jonathan Siegmann believes Nlight's recent stock decline presents an attractive buying opportunity. Over the past week, the stock has slipped about 5% to $47.88, significantly below its 52-week high of $86.95. The company's China-related risks are primarily from non-specialized optical materials and components, such as small mirrors and lenses, and not from proprietary chips or fiber. To counteract these risks, Stifel suggests using short-term over-ordering, establishing medium-term qualified second sources, and pursuing longer-term new supplier qualifications. Additionally, Nlight's primary Department of Defense customer is aware of the issues but not engaging in special access to affected materials, indicating confidence in the company's mitigation strategies and backup suppliers. Financially, Stifel notes that Nlight's robust cash position, with an 8.17 current ratio and more cash than debt, allows it to handle extra inventory costs, qualification expenses, and new optical investments. The broader domestic optics sector is also looking promising, as evidenced by Arlington Capital's recent acquisition of Gooch & Housego, according to Stifel's analysis. Furthermore, nLIGHT, another company in the optics industry, reported second-quarter 2026 earnings surpassing analysts' expectations, with earnings of $0.15 per share on $82.59 million in revenue, while meeting guidance. Despite issuing a weaker third-quarter guidance due to a supply chain disruption expected to delay $17 million in product revenue, nLIGHT maintained a strong Buy rating from Needham with a $90 price target. This rating reflects the company's robust growth in the defense segment, with a 41% year-over-year increase and 72% growth in product revenues. Moreover, nLIGHT's second-quarter revenue grew by 34% year-over-year, exceeding consensus estimates of 27%, and adjusted EBITDA was reported at the upper end of its guidance range.",
  "summary": null,
  "key_points": [
    "Stifel reaffirms Buy rating and $85 price target for Nlight stock",
    "Limited China exposure due to non-specialized optical materials and components",
    "Nlight's robust cash position allows handling extra inventory costs and investments"
  ],
  "editors_take": null,
  "illustration": null,
  "coverage": {
    "outlets": 2,
    "also_reported_by": [
      {
        "outlet": "Investing.com",
        "title": "Stifel reiterates buy rating on IDEXX Laboratories stock at $675",
        "url": "https://urgent.news/2026/08/20/stifel-reiterates-buy-rating-on-idexx-laboratories-stock-at-675",
        "published": "2026-08-20T13:02:54.000Z"
      }
    ]
  },
  "ai_generated": true,
  "disclaimer": "Summaries, key points and the editor’s take are written by software from other outlets’ reporting and may contain errors — always check the linked original."
}